HCWB
HCWB
NASDAQ · Biotechnology

Hcw Biologics Inc

$0.34
-0.01 (-3.55%)
As of May 16, 2:35 AM ET ·
Financial Highlights (FY 2026)
Revenue
174.4K
Net Income
-25,552,557
Gross Margin
20.0%
Profit Margin
-14,677.7%
Rev Growth
-79.9%
D/E Ratio
2.46
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 20.0% 20.0% 30.6% 30.6%
Operating Margin -14,201.5% -12,781.3% -4.2% -3.9%
Profit Margin -14,677.7% -13,943.8% -5.3% -5.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 174.4K 869.5K 478.0K 424.9K
Gross Profit 34.9K 173.8K 146.1K 129.9K
Operating Income -24,769,244 -111,128,213 -20,310 -16,746
Net Income -25,552,557 -114,642,578 -25,168 -22,690
Gross Margin 20.0% 20.0% 30.6% 30.6%
Operating Margin -14,201.5% -12,781.3% -4.2% -3.9%
Profit Margin -14,677.7% -13,943.8% -5.3% -5.3%
Rev Growth -79.9% -79.9% +3.1% +2.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 807.0K 807.0K 286.1K 295.5K
Total Equity 327.7K 327.7K 2.68M 2.44M
D/E Ratio 2.46 2.46 0.11 0.12
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -20,353,828 -96,391,508 -28,783 -26,607
Free Cash Flow -23,138 -19,951